Thus, pharmacologic or other approaches that could modulate macrophage activity and IL-4/IL-6 production in the adipose tissue during aging could be exploited therapeutically in the recovery of beige fat to potentially improve metabolic health, as been done in the field of obesity (38, 39). This evidence concerns the gene IL4 and obesity due to melanocortin 4 receptor deficiency.